Neurology

Researchers investigated whether socioeconomic status (SES) is linked to prescribing patterns of disease-modifying therapy (DMT) in patients with relapsing-remitting multiple sclerosis (pwRRMS) in London. Based on a small sample, SES was not a predictive risk factor for DMT prescribing patterns in patients with pwRRMS. Socioeconomic status (SES), as measured by education, occupation, and income level,...

Gaps exist between unmet need and access to mental health care in patients with MS. Race, ethnicity, and socioeconomic status (SES) are linked to disparities in mental health care in these patients. Patients with multiple sclerosis (MS) are not immune to the psychological and mental effects that the disease can bring about over time. In...

Different groups of individuals with MS may experience potential barriers to care access in different ways. In a survey-based study, researchers assessed how sexual and gender minority (SGM) individuals experience MS care in Northern California. The potential complications of multiple sclerosis (MS) call for a targeted, individualized treatment regimen for many individuals. However, some may...

New challenges in addressing retinal neurodegeneration have emerged as socioeconomic status may play a more critical role than previously thought. Racial disparities in comorbidities associated with multiple sclerosis (MS) may need to be evaluated more closely. Multiple sclerosis (MS) is an inflammatory demyelinating disease that, without proper treatment can progressively affect the central nervous system...

The most socioeconomically disadvantaged groups of individuals may be at increased risk of faster retinal neurodegeneration from multiple sclerosis. Raising awareness on this inequality may help promote the implementation of efficient treatment solutions in patients with low socioeconomic status. Multiple sclerosis is an autoimmune disease characterized by demyelination, inflammation, and neurodegeneration. However, symptoms and outcomes...

Although they have a lower risk of disease severity than adults with NMOSD, pediatric patients with NMOSD are at a higher risk of relapse attacks, motor deficits, and visual disabilities than their adult counterparts. Using a predictive risk score model may help healthcare professionals pinpoint the timeline of relapse and formulate personalized treatment plans. Neuromyelitis...

There is an unmet need to differentiate NMOSD from MS due to the potential effects and safety risks associated with executing the wrong treatment regimen. Infrared spectroscopy coupled with a machine learning algorithm may be a promising point-of-care diagnostic tool. Establishing a diagnosis of neuromyelitis optica spectrum disorder (NMOSD) differentiated from multiple sclerosis (MS) is...

Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated disease (MOGAD) present with overlapping features, which can make a differential diagnosis difficult. Brain and spinal cord magnetic resonance imaging (MRI) is an appropriate method for determining a correct diagnosis. The overlapping clinical features of multiple sclerosis (MS), neuromyelitis optica spectrum...

Calls for parity in clinical trial enrollment among all racial groups, especially Blacks and Hispanics, are being advocated. Considering the aggressive progression of disease in racial and ethnic groups, more drug research is needed in racial groups who may be at higher risk of complications than others. Neuromyelitis optica spectrum disorder (NMOSD) is a progressive,...